Published in Toxicol Pathol on July 09, 2001
Tissue-engineered blood vessels as promising tools for testing drug toxicity. Expert Opin Drug Metab Toxicol (2015) 0.80
Intracellular localization of liver sugar nucleotide glycoprotein glycosyltransferases in a Golgi-rich fraction. J Biol Chem (1970) 4.74
An assay for intercellular adhesive specificity. J Cell Biol (1971) 2.35
Evidence for cell-surface glycosyltransferases. Their potential role in cellular recognition. J Cell Biol (1971) 2.29
Concomitant endothelin receptor subtype-A blockade during the progression of pacing-induced congestive heart failure in rabbits. Beneficial effects on left ventricular and myocyte function. Circulation (1997) 2.05
Prognostic value of urodynamic testing in myelodysplastic patients. J Urol (1981) 2.03
Myocardial contractility in a canine model of the brain-dead organ donor. Crit Care Med (1993) 2.03
Myocardial protection with preconditioning. Circulation (1990) 1.83
Hypercholesterolemia causes mechanical weakening of rabbit atheroma : local collagen loss as a prerequisite of plaque rupture. Circ Res (2000) 1.63
Matrix metalloproteinase inhibition attenuates left ventricular remodeling and dysfunction in a rat model of progressive heart failure. Circulation (2001) 1.59
Matrix metalloproteinase inhibition during the development of congestive heart failure : effects on left ventricular dimensions and function. Circ Res (1999) 1.58
Spontaneous thrombosis in mice carrying the factor V Leiden mutation. Blood (2000) 1.58
Nitric oxide-induced S-glutathionylation and inactivation of glyceraldehyde-3-phosphate dehydrogenase. J Biol Chem (1999) 1.56
Definition and classification of urinary incontinence: recommendations of the Urodynamic Society. Neurourol Urodyn (1997) 1.52
Quality of life after salvage cryotherapy: the impact of treatment parameters. J Urol (1999) 1.51
Treatment results using pubovaginal slings in patients with large cystoceles and stress incontinence. J Urol (1997) 1.47
Modified Ingelman-Sundberg bladder denervation procedure for intractable urge incontinence. J Urol (1996) 1.44
Myocardial revascularization of the canine circumflex coronary artery using retrograde internal mammary artery flow without cardiopulmonary bypass. Ann Thorac Surg (1981) 1.43
The concentration of calcium in neonatal cardioplegia. Ann Thorac Surg (1990) 1.42
Determination of coronary flow reserve by parametric imaging. Circulation (1990) 1.41
Urological diseases of women, and women in urology. J Urol (1999) 1.41
Treatment of motor and sensory detrusor instability by electrical stimulation. J Urol (1983) 1.40
Augmentation cystoplasty and closure of the urethra for the destroyed lower urinary tract. J Am Paraplegia Soc (1990) 1.39
Sexual dysfunction and electroejaculation in men with spinal cord injury: review. J Urol (1988) 1.38
Structure-activity relationships for a novel series of pyrido[2,3-d]pyrimidine tyrosine kinase inhibitors. J Med Chem (1997) 1.38
Our experience with pubovaginal slings in patients with stress urinary incontinence. J Urol (1998) 1.35
Nonuniformity of inner and outer systolic wall thickening in conscious dogs. Am J Physiol (1985) 1.31
Critical subcellular targets of cisplatin and related platinum analogs in rat renal proximal tubule cells. Kidney Int (1995) 1.23
Direct measurement of inner and outer wall thickening dynamics with epicardial echocardiography. Circulation (1986) 1.21
Dissociation between regional myocardial dysfunction and ECG changes during ischemia in the conscious dog. Circulation (1980) 1.21
Stress Urinary Incontinence. Obstet Gynecol (1976) 1.17
Role for endothelin-1 in angiotensin II-mediated hypertension. Hypertension (1997) 1.17
Transvaginal urethrolysis for urethral obstruction after anti-incontinence surgery. J Urol (1998) 1.16
Intercellular adhesive selectivity. II. Properties of embryonic chick liver cell-cell adhesion. J Cell Biol (1976) 1.16
Specificity of the American Urological Association voiding symptom index: comparison of unselected and selected samples of both sexes. J Urol (1993) 1.16
Sustained limitation of myocardial reperfusion injury by a monoclonal antibody that alters leukocyte function. Circulation (1990) 1.15
Enzymatic synthesis of the protein-hexosamine linkage in sheep submaxillary mucin. J Biol Chem (1967) 1.14
Effect of exercise on the relationship between myocardial blood flow and systolic wall thickening in dogs with acute coronary stenosis. Circ Res (1983) 1.14
Sustained regional dysfunction produced by prolonged coronary stenosis: gradual recovery after reperfusion. Circulation (1983) 1.13
Collagen injection for intrinsic sphincteric deficiency in men. J Urol (1996) 1.11
Pubovaginal sling: 4-YEAR outcome analysis and quality of life assessment. J Urol (2000) 1.11
Periurethral collagen for urinary incontinence after gender reassignment surgery. Urology (1993) 1.11
Expression of the human 5-hydroxytryptamine1A receptor in Sf9 cells. Reconstitution of a coupled phenotype by co-expression of mammalian G protein subunits. J Biol Chem (1995) 1.10
Identification of a time window for therapy to reduce experimental canine myocardial injury: suppression of neutrophil activation during 72 hours of reperfusion. Circ Res (1988) 1.09
Abnormal galactosylation of complex carbohydrates in cultured fibroblasts from patients with galactose-1-phosphate uridyltransferase deficiency. Pediatr Res (1992) 1.09
Bladder endometriosis: conservative management. J Urol (2000) 1.09
Incorporation of D-galactose into glycoproteins. J Biol Chem (1965) 1.08
Relationship of physical fitness test results and hockey playing potential in elite-level ice hockey players. J Strength Cond Res (2008) 1.07
The use of modified Martius graft as an adjunctive technique in vesicovaginal and rectovaginal fistula repair. Obstet Gynecol (1990) 1.07
Urodynamic findings in patients after failure of stress incontinence operations. Prog Clin Biol Res (1981) 1.06
Iloprost inhibits neutrophil function in vitro and in vivo and limits experimental infarct size in canine heart. Circ Res (1987) 1.06
Failure of superoxide dismutase and catalase to alter size of infarction in conscious dogs after 3 hours of occlusion followed by reperfusion. Circulation (1986) 1.06
Sialic acids. 13. A uridine diphosphate D-galactose: mucin galactosyltransferase from porcine submaxillary gland. J Biol Chem (1971) 1.05
Electroejaculation for recovery of semen after retroperitoneal lymph node dissection: case report. J Urol (1987) 1.04
Cell-cell adhesion in the embryonic chick: partial purification of liver adhesion molecules from liver membranes. Dev Biol (1981) 1.03
Juvenile canine drug-induced arthropathy: clinicopathological studies on articular lesions caused by oxolinic and pipemidic acids. Toxicol Appl Pharmacol (1979) 1.02
Blunt urethral trauma: a unified, anatomical mechanical classification. J Urol (1997) 1.02
Long-term followup of incontinence and obstruction after salvage cryosurgical ablation of the prostate: results in 143 patients. J Urol (1997) 1.02
Regional myocardial perfusion and wall thickening during ischemia in conscious dogs. Am J Physiol (1984) 1.02
Revision rate after artificial urinary sphincter implantation for incontinence after radical prostatectomy: actuarial analysis. J Urol (2001) 1.01
The distribution of functional impairment across the lateral border of acutely ischemic myocardium. Circ Res (1986) 1.01
Significance of regional wall thickening abnormalities relative to transmural myocardial perfusion in anesthetized dogs. Circulation (1980) 1.01
Upper urinary tract deterioration in patients with myelodysplasia and detrusor hypertonia: a followup study. J Urol (1983) 1.01
Prostacyclin protects ischemic reperfused myocardium in the dog by inhibition of neutrophil activation. Am Heart J (1987) 1.00
Subepicardial segmental function during coronary stenosis and the role of myocardial fiber orientation. Circ Res (1982) 1.00
2-Substituted aminopyrido[2,3-d]pyrimidin-7(8H)-ones. structure-activity relationships against selected tyrosine kinases and in vitro and in vivo anticancer activity. J Med Chem (1998) 0.98
Isolation of diphosphopyridine nucleotide-dependent L-fucose dehydrogenase from pork liver. J Biol Chem (1969) 0.97
Standards of efficacy for evaluation of treatment outcomes in urinary incontinence: recommendations of the Urodynamic Society. Neurourol Urodyn (1997) 0.97
The guarding reflex revisited. Br J Urol (1997) 0.96
Chronic suppurative orchiepididymitis associated with Haemophilus somnus in a calf. J Am Vet Med Assoc (1984) 0.96
Incontinent ileo-vesicostomy urinary diversion in the treatment of lower urinary tract dysfunction. J Urol (1994) 0.96
Effects of coronary occlusion on early ventricular diastolic events in conscious dogs. Am J Physiol (1979) 0.96
Management of urethral obstruction with transvaginal urethrolysis. J Urol (1993) 0.95
Viscus perforation: unusual complication of ureteroneocystostomy. Urology (1974) 0.95
Vulvar vestibulitis and interstitial cystitis: a disorder of urogenital sinus-derived epithelium? Obstet Gynecol (1993) 0.95
Myocardial clearance kinetics of technetium-99m-SQ30217: a marker of regional myocardial blood flow. J Nucl Med (1990) 0.95
The value of urodynamic testing in stress urinary incontinence. J Urol (1980) 0.94
Effects of a calcium-entry blocker (diltiazem) on regional myocardial flow and function during exercise in conscious dogs. Circulation (1984) 0.94
Carcinogenesis bioassay of prazepam (Verstran) in rats and mice. Toxicol Appl Pharmacol (1981) 0.94
Augmenting intracellular adenosine improves myocardial recovery. J Thorac Cardiovasc Surg (1990) 0.93
Incorporation of N-acetyl-D-glucosamine into glycoproteins. J Biol Chem (1966) 0.93
Superoxide dismutase conjugated to polyethylene glycol provides sustained protection against myocardial ischemia/reperfusion injury in canine heart. Circ Res (1988) 0.93
Neutrophils are not necessary for induction of ischemia-reperfusion lung injury. J Appl Physiol (1985) (1990) 0.93
In vitro pharmacological characterization of PD 166285, a new nanomolar potent and broadly active protein tyrosine kinase inhibitor. J Pharmacol Exp Ther (1997) 0.93
Canine myocardial reperfusion injury: protection by a free radical scavenger, N-2-mercaptopropionyl glycine. J Cardiovasc Pharmacol (1986) 0.93
Effect of superoxide dismutase on myocardial infarct size in the canine heart after 6 hours of regional ischemia and reperfusion: a demonstration of myocardial salvage. Circ Res (1989) 0.92
Angiotensin-converting enzyme and matrix metalloproteinase inhibition with developing heart failure: comparative effects on left ventricular function and geometry. J Pharmacol Exp Ther (1999) 0.92
The physiologic basis of dobutamine as compared with dipyridamole stress interventions in the assessment of critical coronary stenosis. Circulation (1987) 0.92
Long-term results and complications using augmentation cystoplasty in reconstructive urology. Neurourol Urodyn (1995) 0.91
Management of female genitourinary fistulas: transvesical or transvaginal approach? J Urol (1998) 0.91
Renal angiomyolipoma: diagnosis and management. Urology (1980) 0.91
Management of female urethral diverticula: a new classification. J Urol (1998) 0.91
The sialic acids. XVI. Isolation of a mucin sialyltransferase from sheep submaxillary gland. J Biol Chem (1973) 0.91
Toilet habits and continence in children: an opportunity sampling in search of normal parameters. J Urol (1993) 0.91
End-systolic dimension-wall thickness relations during myocardial ischemia in conscious dogs. A new approach for defining regional function. Am J Cardiol (1983) 0.90
Intercellular adhesive selectivity. III. Species selectivity of embryonic liver intercellular adhesion. J Cell Biol (1976) 0.90
Pretreatment with endothelin-1 mimics ischemic preconditioning against infarction in isolated rabbit heart. J Mol Cell Cardiol (1996) 0.90
CL-845 (pirmenol hydrochloride): a new orally effective long-acting antiarrhythmic agent. J Pharmacol Exp Ther (1980) 0.90
Long-term followup of spinal cord injury patients managed by intermittent catheterization. J Urol (1983) 0.89